
Publikationen von T. Nickel
Alle Typen
Zeitschriftenartikel (24)
1.
Zeitschriftenartikel
44 (15), S. 1063 - 1068 (2010)
Response and remission criteria in major depression - A validation of current practice. Journal of Psychiatric Research 2.
Zeitschriftenartikel
42 (5), S. 222 - 222 (2009)
Clinical characteristics and treatment outcome in a representative sample of depressed inpatients - Findings from the Munich Antidepressant Response Signature project. Pharmacopsychiatry 3.
Zeitschriftenartikel
34 (1), S. 99 - 109 (2009)
HPA-axis regulation at in-patient admission is associated with antidepressant therapy outcome in male but not in female depressed patients. Psychoneuroendocrinology 4.
Zeitschriftenartikel
43 (3), S. 215 - 229 (2009)
Clinical characteristics and treatment outcome in a representative sample of depressed inpatients - Findings from the Munich Antidepressant Response Signature (MARS) project. Journal of Psychiatric Research 5.
Zeitschriftenartikel
13 (Suppl. 1), S. 31 - 32 (2009)
Clinical characteristics and treatment outcome in a representative sample of depressed inpatients - findings from the Munich antidepressant response signature project. International Journal of Psychiatry in Clinical Practice 6.
Zeitschriftenartikel
28 (1), S. 105 - 107 (2008)
Successful treatment of chronic fatigue syndrome with duloxetine and trijodthyronine - A case study. Journal of Clinical Psychopharmacology 7.
Zeitschriftenartikel
34 (2), S. 93 - 94 (2007)
Gabapentin bei einer Patientin mit Panikstörung und Unverträglichkeit von Carbamazepin während des Benzodiazepinentzugs. Psychiatrische Praxis 8.
Zeitschriftenartikel
26 (6), S. 676 - 677 (2006)
Possible case of quetiapine-induced rhabdomyolysis in a patient with depression treated with fluoxetine. Journal of Clinical Psychopharmacology 9.
Zeitschriftenartikel
29 (6), S. 1085 - 1093 (2005)
The combined dexamethasone/CRH test as a potential surrogate marker in depression. Progress in Neuro-Psychopharmacology & Biological Psychiatry 10.
Zeitschriftenartikel
39 (2), S. 173 - 177 (2005)
Treatment with a CRH-1-receptor antagonist (R121919) does not affect weight or plasma leptin concentration in patients with major depression. Journal of Psychiatric Research 11.
Zeitschriftenartikel
38 (2), S. 102 - 104 (2005)
Depression during therapy with interferon α - How long should an antidepressant treatment last? A case report. Pharmacopsychiatry 12.
Zeitschriftenartikel
12 (3), S. 164 - 168 (2004)
Lower targets for weekly weight gain lead to better results in inpatient treatment of anorexia nervosa: A pilot study. European Eating Disorders Review 13.
Zeitschriftenartikel
38 (2), S. 219 - 221 (2004)
Long-latency somatosensory potentials in high risk probands for affective disorders. Journal of Psychiatric Research 14.
Zeitschriftenartikel
36, S. 1319 - 1325 (2004)
Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment. Nature Genetics 15.
Zeitschriftenartikel
28 (12), S. 2169 - 2178 (2003)
Pharmacological and nonpharmacological factors influencing hypothalamic-pituitary-adrenocortical axis reactivity in acutely depressed psychiatric in-patients, measured by the Dex-CRH test. Neuropsychopharmacology 16.
Zeitschriftenartikel
37 (6), S. 525 - 533 (2003)
Treatment of depression with the CRH-1-receptor antagonist R121919: endocrine changes and side effects. Journal of Psychiatric Research 17.
Zeitschriftenartikel
36 (5), S. 216 - 216 (2003)
Prediction of response to antidepressant monotherapy. Pharmacopsychiatry 18.
Zeitschriftenartikel
36 (5), S. 237 - 237 (2003)
Subsyndromal AMDP scales to distinguish pathogenetically homogenous subgroups of affective disorders. Pharmacopsychiatry 19.
Zeitschriftenartikel
23 (2), S. 155 - 168 (2003)
Clinical and neurobiological effects of tianeptine and paroxetine in major depression. Journal of Clinical Psychopharmacology 20.
Zeitschriftenartikel
28 (2), S. 348 - 358 (2003)
State markers of depression in sleep EEG: Dependency on drug and gender in patients treated with tianeptine or paroxetine. Neuropsychopharmacology